TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34008856

Group type: EXPERIMENTAL
Intervention: Astragalus polysaccharide (APS) at concentrations of 40, 100, or 400 μg/mL
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (Ctrl group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: FA-treated cells (FA group, 120 μmol/L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FA + APS groups (with APS concentrations)
Number of subjects: 0
Study: 33499027

Group type: EXPERIMENTAL
Intervention: COVID-19-related quarantine
Number of subjects: 359
Study: 34510196

Group type: EXPERIMENTAL
Intervention: Auditory Training (AT)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Control Condition (Computer Games - CG)
Number of subjects: 147
Study: 32297373

Group type: EXPERIMENTAL
Intervention: 5As model of brief intervention (ask, advise, assess, assist, arrange)
Number of subjects: 1047
Study: 34798201

Group type: EXPERIMENTAL
Intervention: Guselkumab
Number of subjects: 1721
Study: 34403780

Group type: EXPERIMENTAL
Intervention: eatNplay group videoconferencing telehealth sessions
Number of subjects: 44

Group type: COMPARATOR
Intervention: Monthly newsletters
Number of subjects: 44
Study: 32343261

Group type: EXPERIMENTAL
Intervention: Male
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Female
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Both genders
Number of subjects: 222
Study: 34845352

Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo)
Number of subjects: 750

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 750
Study: 33050833

Group type: EXPERIMENTAL
Intervention: Naltrexone (mu-opioid blocker)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35665745

Group type: EXPERIMENTAL
Intervention: NVSI-06-07
Number of subjects: 1800

Group type: COMPARATOR
Intervention: BBIBP-CorV
Number of subjects: 1800
Study: 32032997

Group type: EXPERIMENTAL
Intervention: DieTBra (traditional Brazilian diet)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Olive oil (52 mL/day)
Number of subjects: 111
Study: 35505631

Group type: EXPERIMENTAL
Intervention: Adjusted motor IFC
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo IFC
Number of subjects: 102
Study: 33677837

Group type: EXPERIMENTAL
Intervention: Anti-drinking comments
Number of subjects: 723

Group type: EXPERIMENTAL
Intervention: Warning labels
Number of subjects: 723

Group type: EXPERIMENTAL
Intervention: Pro-drinking comments
Number of subjects: 723

Group type: EXPERIMENTAL
Intervention: Industry responsibility messages
Number of subjects: 723
Study: 32462921

Group type: EXPERIMENTAL
Intervention: Angiotensin II as an add-on vasopressor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Norepinephrine as first-line vasopressor
Number of subjects: 0
Study: 34814232

Group type: EXPERIMENTAL
Intervention: Black myrobalan (500 mg capsules, six capsules per day for 4 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32784117

Group type: EXPERIMENTAL
Intervention: Idebenone
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 35975297

Group type: EXPERIMENTAL
Intervention: CMV IgG titer
Number of subjects: 672
Study: 33517683

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering (systolic BP <120 mm Hg)
Number of subjects: 9286

Group type: COMPARATOR
Intervention: Standard blood pressure treatment
Number of subjects: 9286
Study: 34879226

Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 60

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 33372830

Group type: EXPERIMENTAL
Intervention: Single-Stranded Tag Hybridization Chromatographic Printed-Array Strip (STH-PAS) method
Number of subjects: 378
Study: 36073737

Group type: EXPERIMENTAL
Intervention: Additional $40 per month in fruit and vegetable benefits for WIC participants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard WIC benefits (control group)
Number of subjects: 0
Study: 33002318

Group type: EXPERIMENTAL
Intervention: Exercise-induced bronchoconstriction (EIB) test
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Continuous laryngoscopy exercise (CLE) test
Number of subjects: 367
Study: 34811505

Group type: EXPERIMENTAL
Intervention: ctDNA positive patients
Number of subjects: 354

Group type: COMPARATOR
Intervention: ctDNA negative patients
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: ctDNA status (positive vs negative)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: ctDNA as a prognostic marker
Number of subjects: 354
Study: 35800975

Group type: EXPERIMENTAL
Intervention: Active meditation program (once a week for three months)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 22
Study: 32940679

Group type: COMPARATOR
Intervention: Standard recumbent bike for 15 to 20 minutes each session (Control)
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Body weight‐adjustable treadmill for 15 to 20 minutes each session
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Patterned electrical neuromuscular stimulation device for 15 to 20 minutes each session
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Combination of the treadmill and electrical neuromuscular stimulation for 15 to 20 minutes each session
Number of subjects: 386
Study: 34948828

Group type: EXPERIMENTAL
Intervention: PrepCheck® (PC)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Dental Teacher™ (DT)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Faculty Feedback (FF)
Number of subjects: 97
Study: 35257386

Group type: EXPERIMENTAL
Intervention: Tree Theme Method (TTM)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Care as usual (control)
Number of subjects: 118
Study: 32375741

Group type: EXPERIMENTAL
Intervention: Integrated pediatric TB services into child healthcare services, consisting of training, supportive supervision, job aids, and logistical support.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care offering pediatric TB services based on national standard of care.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Integrated pediatric TB services into child healthcare services.
Number of subjects: 0
Study: 33289598

Group type: EXPERIMENTAL
Intervention: Continuous antibiotic prophylaxis
Number of subjects: 607

Group type: COMPARATOR
Intervention: Control (not receiving continuous antibiotic prophylaxis as per model recommendation)
Number of subjects: 607
Study: 32384885

Group type: EXPERIMENTAL
Intervention: 2-h training involving 10 written clinical cases (experimental)
Number of subjects: 87

Group type: COMPARATOR
Intervention: 1-h lecture and 1-h outpatient clinic (lecture)
Number of subjects: 87

Group type: COMPARATOR
Intervention: 2-h outpatient clinic (no intervention)
Number of subjects: 87
Study: 34083231

Group type: EXPERIMENTAL
Intervention: Once‐every‐3‐weeks cisplatin at 100 mg/m2 for two cycles
Number of subjects: 510

Group type: COMPARATOR
Intervention: Once‐a‐week cisplatin at 40 mg/m2 for six cycles
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Once‐every‐3‐weeks cisplatin
Number of subjects: 510

Group type: COMPARATOR
Intervention: Once‐a‐week cisplatin
Number of subjects: 510
Study: 33899624

Group type: EXPERIMENTAL
Intervention: Enhanced Milieu Teaching with Phonological Emphasis (EMT+PE)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Business-as-usual (BAU)
Number of subjects: 24
Study: 36443661

Group type: EXPERIMENTAL
Intervention: WBV alone
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: WV alone
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: WBV + WV
Number of subjects: 51
Study: 33905482

Group type: EXPERIMENTAL
Intervention: Hyperthermia at 44C
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control (37C)
Number of subjects: 53
Study: 32178633

Group type: EXPERIMENTAL
Intervention: On The Move (OTM) group-exercise program
Number of subjects: 248

Group type: COMPARATOR
Intervention: Seated exercise program (usual-care)
Number of subjects: 248
Study: 34759131

Group type: EXPERIMENTAL
Intervention: DCB
Number of subjects: 184

Group type: COMPARATOR
Intervention: DES
Number of subjects: 184
Study: 34714211

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: One-anastomosis gastric bypass (OAGB)
Number of subjects: 17
Study: 34542017

Group type: EXPERIMENTAL
Intervention: Bio-banded (BB) competition
Number of subjects: 65

Group type: COMPARATOR
Intervention: Chronological age (CA) competition
Number of subjects: 65
Study: 33838758

Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 520

Group type: COMPARATOR
Intervention: Valproate
Number of subjects: 520
Study: 35266898

Group type: EXPERIMENTAL
Intervention: Animation and gamification in online distance education
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no animation and gamification)
Number of subjects: 70
Study: 32396519

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 or 10 mg twice daily
Number of subjects: 3330

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3330
Study: 33276036

Group type: EXPERIMENTAL
Intervention: Synchronous tACS (55 Hz enveloped by 6 Hz)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Desynchronous tACS (55 Hz enveloped by 6 Hz)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham tACS
Number of subjects: 45
Study: 32214299

Group type: EXPERIMENTAL
Intervention: Paramedian approach of lumbar epidural injection (LEI)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Midline approach of lumbar epidural injection (LEI)
Number of subjects: 104
Study: 36192937

Group type: EXPERIMENTAL
Intervention: Positive condition (engaging sensory task)
Number of subjects: 59
Study: 33688090

Group type: EXPERIMENTAL
Intervention: Open suction systems (OSS)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Closed suction systems (CSS)
Number of subjects: 66
Study: 32883724

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention to improve adherence to cardiac rehabilitation (CR) and cardiovascular medications.
Number of subjects: 31
Study: 35718871

Group type: EXPERIMENTAL
Intervention: n‐3 PUFA supplementation
Number of subjects: 782
Study: 33860790

Group type: EXPERIMENTAL
Intervention: Propranolol (n = 42)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo (n = 45)
Number of subjects: 87
Study: 34359017

Group type: EXPERIMENTAL
Intervention: Chinese Metacognitions about Smartphone Use Questionnaire (Chinese MSUQ)
Number of subjects: 698
Study: 34569334

Group type: EXPERIMENTAL
Intervention: Intravenous injection of 2 g tranexamic acid (TXA) and local use of 1 g intraoperatively (Group B)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of 2 g tranexamic acid (TXA) and 10 mg rivaroxaban qd treatment postoperatively (Group C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.9% NaCl solution intravenously (Group A)
Number of subjects: 0
Study: 34380473

Group type: EXPERIMENTAL
Intervention: Piezo-surgery
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Piezo-surgery with 8 mg dexamethasone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Piezo-surgery without dexamethasone
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional rotatory without dexamethasone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Piezo-surgery with dexamethasone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Conventional rotatory with dexamethasone
Number of subjects: 80
Study: 32041957

Group type: EXPERIMENTAL
Intervention: Plasma levels of 90 neurology-related proteins
Number of subjects: 798

Group type: EXPERIMENTAL
Intervention: MRI-assessed total brain volume
Number of subjects: 798

Group type: COMPARATOR
Intervention: Plasma levels of neurology-related proteins in INTERVAL
Number of subjects: 798
Study: 35803172

Group type: EXPERIMENTAL
Intervention: Dual bronchodilator therapy with umeclidinium bromide (UMEC)/vilanterol (VI)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Monotherapy with umeclidinium bromide (UMEC)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Monotherapy with salmeterol (SAL)
Number of subjects: 1000
Study: 34489263

Group type: EXPERIMENTAL
Intervention: Shorter, more tolerable regimens of oral drugs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study: 32302083

Group type: EXPERIMENTAL
Intervention: 1-stage BTHA
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: 1-stage BTKA
Number of subjects: 195
Study: 33942560

Group type: EXPERIMENTAL
Intervention: Atogepant 300 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32348699

Group type: EXPERIMENTAL
Intervention: short-term existential behavioural therapy (sEBT); 2 individual 1-h sessions
Number of subjects: 157

Group type: COMPARATOR
Intervention: active control
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: sEBT or active control
Number of subjects: 157
Study: 36189985

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg, once daily)
Number of subjects: 11007

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11007
Study: 33128587

Group type: EXPERIMENTAL
Intervention: BPTB with standard rehabilitation
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: BPTB with accelerated rehabilitation
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: HT with standard rehabilitation
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: HT with accelerated rehabilitation
Number of subjects: 160
Study: 32402953

Group type: EXPERIMENTAL
Intervention: Exercise group (36 weeks swimming program, 3 sessions per week)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (recreational swimming program, 2 sessions per week for 36 weeks)
Number of subjects: 45
Study: 33784898

Group type: EXPERIMENTAL
Intervention: Plan A (entertainment-education video intervention)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Neutral control condition
Number of subjects: 242
Study: 34426648

Group type: EXPERIMENTAL
Intervention: Weight-loss dietary intervention
Number of subjects: 395
Study: 33231036

Group type: EXPERIMENTAL
Intervention: Manipulating mate availability
Number of subjects: 1950

Group type: COMPARATOR
Intervention: Manipulating pathogen threat
Number of subjects: 1950
Study: 34775948

Group type: EXPERIMENTAL
Intervention: Modified high-flow nasal cannula (HFNC) oxygen therapy
Number of subjects: 788

Group type: COMPARATOR
Intervention: Conventional oxygen therapy (COT)
Number of subjects: 788
Study: 34750724

Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia (IH) via a mask, mean SpO2 of 85%, 70 min of hypoxia
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham-intermittent hypoxia (Sham-IH) control
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Continuous hypoxia (CH) via a mask, mean SpO2 of 85%, 70 min of hypoxia
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham-control for continuous hypoxia (Sham-CH)
Number of subjects: 10
Study: 32034697

Group type: EXPERIMENTAL
Intervention: Plasma endostatin levels (≥ 84.22 ng/mL)
Number of subjects: 613

Group type: EXPERIMENTAL
Intervention: Plasma endostatin levels (highest vs lowest quartile)
Number of subjects: 613

Group type: EXPERIMENTAL
Intervention: Adding endostatin to a model containing conventional factors
Number of subjects: 613
Study: 34847750

Group type: EXPERIMENTAL
Intervention: GRAIL GalleriTM multi-cancer screening test (screening)
Number of subjects: 140000

Group type: COMPARATOR
Intervention: Unexposed (no screening)
Number of subjects: 140000
Study: 32955200

Group type: EXPERIMENTAL
Intervention: AXA1665 14.7 g t.i.d.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control t.i.d.
Number of subjects: 40
Study: 35022179

Group type: EXPERIMENTAL
Intervention: MindOnLine programme (n=200)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Waitlist control (n=200)
Number of subjects: 400
Study: 35790435

Group type: EXPERIMENTAL
Intervention: Proposed helical CT projection data restoration model
Number of subjects: 0

Group type: COMPARATOR
Intervention: IRLNet, REDCNN, MWResNet
Number of subjects: 0
Study: 32994381

Group type: EXPERIMENTAL
Intervention: Aerobic aquatic training
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Combined aquatic training
Number of subjects: 3

Group type: COMPARATOR
Intervention: Procedure control
Number of subjects: 3
Study: 36369133

Group type: EXPERIMENTAL
Intervention: Electroacupuncture and intradermal press needles (Acupuncture group, n=35)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (n=29)
Number of subjects: 64
Study: 33515536

Group type: EXPERIMENTAL
Intervention: Active HD-tDCS targeting the dACC
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sham HD-tDCS
Number of subjects: 23
Study: 32216457

Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 34670131

Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone (BUP-NX), n = 287
Number of subjects: 570

Group type: COMPARATOR
Intervention: Extended-release naltrexone injection (XR-NTX), n = 283
Number of subjects: 570
Study: 32350694

Group type: EXPERIMENTAL
Intervention: Patient group (angle α = 38.56°)
Number of subjects: 671

Group type: COMPARATOR
Intervention: Control group (age- and sex-matched, angle α = 48.48°)
Number of subjects: 671
Study: 35351180

Group type: EXPERIMENTAL
Intervention: Super Bolus
Number of subjects: 72

Group type: COMPARATOR
Intervention: Normal Bolus
Number of subjects: 72
Study: 33734145

Group type: EXPERIMENTAL
Intervention: Principal component analysis (n = 1100)
Number of subjects: 2111

Group type: COMPARATOR
Intervention: Confirmatory factor analysis (n = 1011)
Number of subjects: 2111

Group type: EXPERIMENTAL
Intervention: Physiological Pain Measures
Number of subjects: 2111

Group type: EXPERIMENTAL
Intervention: Behavioral Pain Measures
Number of subjects: 2111
Study: 32824408

Group type: EXPERIMENTAL
Intervention: Meal Replacement (MR)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Whole Food (WF)
Number of subjects: 8
Study: 35225510

Group type: EXPERIMENTAL
Intervention: Intravitreal antifungal agents and systemic therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitrectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Newer molecular microbiological technologies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antifungal stewardship
Number of subjects: 0
Study: 32460239

Group type: EXPERIMENTAL
Intervention: Chocolate-flavored dairy milk recovery beverage (1.2 g/kg body mass carbohydrate and 0.4 g/kg body mass protein)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Water volume equivalent
Number of subjects: 11
Study: 35168142

Group type: EXPERIMENTAL
Intervention: Cenobamate 200 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cenobamate 400 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cenobamate 200 mg/day and 400 mg/day with SCBs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cenobamate with non-SCB ASMs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33788024

Group type: EXPERIMENTAL
Intervention: High-dose purified EPA (icosapent ethyl)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment (statins)
Number of subjects: 0
Study: 32770968

Group type: EXPERIMENTAL
Intervention: Low physical activity
Number of subjects: 2047

Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 2047

Group type: EXPERIMENTAL
Intervention: Unhealthy diet
Number of subjects: 2047

Group type: EXPERIMENTAL
Intervention: Dyslipidemia
Number of subjects: 2047

Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 2047

Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 2047

Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 2047

Group type: EXPERIMENTAL
Intervention: Self-reported feeling sad
Number of subjects: 2047

Group type: EXPERIMENTAL
Intervention: History of periods of stress
Number of subjects: 2047

Group type: EXPERIMENTAL
Intervention: Permanent stress
Number of subjects: 2047

Group type: EXPERIMENTAL
Intervention: History of stroke
Number of subjects: 2047

Group type: EXPERIMENTAL
Intervention: Heart failure
Number of subjects: 2047

Group type: EXPERIMENTAL
Intervention: Coronary heart disease (CHD)
Number of subjects: 2047

Group type: COMPARATOR
Intervention: Comparison of men vs women
Number of subjects: 2047

Group type: COMPARATOR
Intervention: Comparison of urban vs rural areas
Number of subjects: 2047

Group type: COMPARATOR
Intervention: Comparison of younger vs older participants
Number of subjects: 2047
Study: 33734167

Group type: EXPERIMENTAL
Intervention: HP-3070 3.8 mg/24 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HP-3070 7.6 mg/24 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HP-3070 (daily application)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HP-3070 with external heat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HP-3070
Number of subjects: 0
Study: 32530717

Group type: COMPARATOR
Intervention: Group seated rest in a relaxing environment (SR)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Yoga-based physical therapy (YPT)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Conventional physical therapy (CPT)
Number of subjects: 11
Study: 32989470

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (5 mg intravenous injection) plus calcitriol (0.5 μg/day) and calcium carbonate (1000 mg/day)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (calcitriol 0.5 μg/day and calcium carbonate 1000 mg/day without ZOL)
Number of subjects: 95
Study: 32446280

Group type: EXPERIMENTAL
Intervention: Performance-based financing (PBF) intervention
Number of subjects: 205
Study: 35642923

Group type: EXPERIMENTAL
Intervention: Parenteral vitamin B12 (1000 µg IM for initial dose, followed by 3 doses on alternate days for <10 years or 5 doses for >10 years, then monthly 1000 µg IM)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Oral vitamin B12 (1500 µg daily for 3 months, 500 µg for <2 years)
Number of subjects: 80
Study: 35274362

Group type: EXPERIMENTAL
Intervention: Chatbot intervention based on the StudentBodies© program
Number of subjects: 700

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 700
Study: 34047303

Group type: EXPERIMENTAL
Intervention: Tegaserod 6 mg b.i.d.
Number of subjects: 2939

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2939
Study: 32388179

Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention (ILI)
Number of subjects: 1945

Group type: COMPARATOR
Intervention: Diabetes Support and Education (DSE)
Number of subjects: 1945
Study: 34931904

Group type: EXPERIMENTAL
Intervention: Walking meditation
Number of subjects: 68

Group type: COMPARATOR
Intervention: Balance training
Number of subjects: 68